Steven Troy

1.7k total citations
49 papers, 1.3k citations indexed

About

Steven Troy is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Steven Troy has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Molecular Biology. Recurrent topics in Steven Troy's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Analytical Methods in Pharmaceuticals (7 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Steven Troy is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Analytical Methods in Pharmaceuticals (7 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Steven Troy collaborates with scholars based in United States, Canada and United Kingdom. Steven Troy's co-authors include G. Muralidharan, Donald G. Raible, Marlynne Micalizzi, John Speth, Soong T. Chiang, Richard J. Fruncillo, Vernon D. Parker, Géraldine M. Ferron, Mona Darwish and Irwin Lucki and has published in prestigious journals such as Journal of the American College of Cardiology, Cancer Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Steven Troy

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Troy United States 19 494 322 218 217 164 49 1.3k
H. Friedman United States 24 341 0.7× 85 0.3× 204 0.9× 121 0.6× 228 1.4× 53 1.3k
Timi Edeki United States 19 450 0.9× 265 0.8× 336 1.5× 180 0.8× 57 0.3× 41 1.6k
Jacqueline B. McCrea United States 26 297 0.6× 93 0.3× 81 0.4× 184 0.8× 45 0.3× 77 2.0k
G.J. Krol United States 18 398 0.8× 115 0.4× 143 0.7× 190 0.9× 156 1.0× 37 1.1k
Keri Wellington New Zealand 26 271 0.5× 43 0.1× 172 0.8× 329 1.5× 57 0.3× 54 1.9k
J. B. Fourtillan France 21 451 0.9× 127 0.4× 35 0.2× 232 1.1× 49 0.3× 68 1.7k
William A. Wargin United States 23 408 0.8× 53 0.2× 500 2.3× 249 1.1× 185 1.1× 54 1.9k
EJ Begg New Zealand 13 283 0.6× 64 0.2× 76 0.3× 128 0.6× 32 0.2× 19 851
John P. Gonzalez United Kingdom 13 220 0.4× 41 0.1× 56 0.3× 191 0.9× 229 1.4× 26 918
Michael Skinner United States 16 412 0.8× 16 0.0× 207 0.9× 280 1.3× 85 0.5× 25 1.4k

Countries citing papers authored by Steven Troy

Since Specialization
Citations

This map shows the geographic impact of Steven Troy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Troy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Troy more than expected).

Fields of papers citing papers by Steven Troy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Troy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Troy. The network helps show where Steven Troy may publish in the future.

Co-authorship network of co-authors of Steven Troy

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Troy. A scholar is included among the top collaborators of Steven Troy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Troy. Steven Troy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Paul D., Steven Troy, R. J. Weiss, et al.. (2021). Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density. Clinical Drug Investigation. 41(3). 277–285. 15 indexed citations
2.
Troy, Steven, et al.. (2021). ANTI-PLATELET, OR ANTI-NEUTROPHIL? A CASE OF CLOPIDOGREL-INDUCED NEUTROPENIA. Journal of the American College of Cardiology. 77(18). 2531–2531.
3.
Flach, Stephen, et al.. (2016). A Phase I Study to Investigate the Absorption, Pharmacokinetics, and Excretion of [14C]Prucalopride After a Single Oral Dose in Healthy Volunteers. Clinical Therapeutics. 38(9). 2106–2115. 12 indexed citations
4.
Flach, Stephen, et al.. (2016). Pharmacokinetics, absorption, and excretion of radiolabeled revexepride: a Phase I clinical trial using a microtracer and accelerator mass spectrometry-based approach. Drug Design Development and Therapy. Volume 10. 3125–3132. 4 indexed citations
5.
Besses, Carlos, W. Zeller, Alberto Álvarez‐Larrán, et al.. (2012). Pharmacokinetics and tolerability of anagrelide hydrochloride in young (18 50 years) and elderly (? 65 years) patients with essential thrombocythemia. International Journal of Clinical Pharmacology and Therapeutics. 50(11). 787–796. 8 indexed citations
6.
Korth‐Bradley, Joan, Steven Troy, Kyle Matschke, et al.. (2011). Tigecycline Pharmacokinetics in Subjects With Various Degrees of Renal Function. The Journal of Clinical Pharmacology. 52(9). 1379–1387. 34 indexed citations
7.
Ferron, Géraldine M., et al.. (2002). Multiple‐Dose, Linear, Dose‐Proportional Pharmacokinetics of Retigabine in Healthy Volunteers. The Journal of Clinical Pharmacology. 42(2). 175–182. 73 indexed citations
8.
Hetta, Jerker, Jan‐Erik Broman, Mona Darwish, & Steven Troy. (2000). Psychomotor effects of zaleplon and thioridazine coadministration. European Journal of Clinical Pharmacology. 56(3). 211–217. 8 indexed citations
9.
Rosen, A., et al.. (1999). Zaleplon pharmacokinetics and absolute bioavailability. Biopharmaceutics & Drug Disposition. 20(3). 171–175. 66 indexed citations
10.
Patat, Alain, et al.. (1998). Absolute Bioavailability and Electroencephalographic Effects of Conventional and Extended‐Release Formulations of Venlafaxine in Healthy Subjects. The Journal of Clinical Pharmacology. 38(3). 256–267. 29 indexed citations
11.
Troy, Steven, Richard L. Rudolph, Michael Mayersohn, & Soong T. Chiang. (1998). The Influence of Cimetidine on the Disposition Kinetics of the Antidepressant Venlafaxine. The Journal of Clinical Pharmacology. 38(5). 467–474. 12 indexed citations
12.
Troy, Steven, et al.. (1997). Pharmacokinetics and Effect of Food on The Bioavailability of Orally Administered Venlafaxine. The Journal of Clinical Pharmacology. 37(10). 954–961. 29 indexed citations
13.
Troy, Steven, et al.. (1997). Pharmacokinetic and Pharmacodynamic Evaluation of the Potential Drug Interaction Between Venlafaxine and Ethanol. The Journal of Clinical Pharmacology. 37(11). 1073–1081. 7 indexed citations
14.
Fruncillo, Richard J., Steven Troy, Vernon D. Parker, et al.. (1996). Pharmacokinetics of the aldose reductase inhibitor tolrestat: Studies in healthy young and elderly male and female subjects and in subjects with diabetes. Clinical Pharmacology & Therapeutics. 59(6). 603–612. 4 indexed citations
15.
Troy, Steven, et al.. (1996). Pharmacokinetic Interaction Between Multiple‐Dose Venlafaxine and Single‐Dose Lithium. The Journal of Clinical Pharmacology. 36(2). 175–181. 20 indexed citations
16.
Troy, Steven, Vernon D. Parker, Richard J. Fruncillo, & Soong T. Chiang. (1995). The Pharmacokinetics of Venlafaxine When Given in a Twice‐Daily Regimen. The Journal of Clinical Pharmacology. 35(4). 404–409. 62 indexed citations
17.
Troy, Steven, et al.. (1995). The Dose Proportionality of the Pharmacokinetics of Ardeparin, a Low Molecular Weight Heparin, in Healthy Volunteers. The Journal of Clinical Pharmacology. 35(12). 1194–1199. 6 indexed citations
18.
Troy, Steven, Robert W. Schultz, Vernon D. Parker, Soong T. Chiang, & Robert A. Blum. (1994). The effect of renal disease on the disposition of venlafaxine. Clinical Pharmacology & Therapeutics. 56(1). 14–21. 44 indexed citations
19.
Troy, Steven, et al.. (1991). The Absolute Bioavailability and Dose Proportionality of Intravenous and Oral Dosage Regimens of Recainam. The Journal of Clinical Pharmacology. 31(5). 433–439.
20.
Scatina, JoAnn, et al.. (1990). Species differences in the pharmacokinetics of recainam, a new anti‐arrhythmic drug. Biopharmaceutics & Drug Disposition. 11(5). 445–461. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Friedman Breakdown of academic impact, for papers by Timi Edeki Breakdown of academic impact, for papers by Jacqueline B. McCrea Breakdown of academic impact, for papers by G.J. Krol Breakdown of academic impact, for papers by Keri Wellington Breakdown of academic impact, for papers by J. B. Fourtillan Breakdown of academic impact, for papers by William A. Wargin Breakdown of academic impact, for papers by EJ Begg Breakdown of academic impact, for papers by John P. Gonzalez Breakdown of academic impact, for papers by Michael Skinner
Rankless by CCL
2026